Characterization of a glial cell-specific DNA-protein complex formed with the human T cell lymphotropic virus type I (HTLV-I) enhancer

References

• Akagi T, Hoshida Y, Yoshino T, Teramoto N, Kondo E, Hayashi K, Takahaski K. Infectivity of human T-cell leukemia virus type I to human nervous tissue cells in vitro. Acta Neuropathol 1992; 84: 147–52
   Google Scholar
• Armstrong A P, Franklin A A, Uittenbogaard M N, Giebler H A, Nyborg J. Pleiotropic effect of the human T-cell leukemia virus Tax protein on the DNA binding activity of eukaryotic transcription factors. Proc Natl Acad Sci USA 1993; 90: 7303–7307
   PubMed Web of Science ®Google Scholar
• Brindle P K, Montminy M R. The CREB family of transcription activatiors. Curr Opin Genet Dev 1992; 2: 199–204
   PubMedGoogle Scholar
• Bhagvati S, Ehrlich G, Kula R W, Kwok S, Sninsky J, Udani V, Poiesz B H. Detection of human T-cell lymphoma/leukemia virus type 1 DNA and antigen in spinal fluid and blood of patients with chronic progressive myelopathy. N Engl J Med 1988; 318: 1141–1147
   Google Scholar
• Bhigjee A I, Wiley C A, Wachsman W, Amenomori T, Pirie D, Bill P LA, Windsor I. HTLV-I-associated myelopathy: Clinicopathologic correlation with localization of provirus to the spinal cord. Neurology 1991; 41: 1990–1992
   Google Scholar
• Bradford M M. A rapid sensitive method for the quantitation of microgram quantities of proteins utilizing the principle of protein-dye binding. Anal Biochem 1976; 72: 248–254
   PubMed Web of Science ®Google Scholar
• Celander D, Haseltine W A. Tissue-specific transcription preference as a determinant of cell tropism and leukaemogenic potential of murine retroviruses. Nature, (London) 1984; 312: 159–162
   PubMedGoogle Scholar
• Chatis P A, Holland C A, Hartley J W., Rowe W P, Hopkins N. Role for the 3' end of the genome in determining dissease specificity of Friend and Moloney murine leukemia virsues. Proc Natl Acad Sci USA 1983; 80: 4408–4411
   PubMedGoogle Scholar
• Corboy J R, Buzy J M, Zink M C, Clements J E. Expression directed from HIV long terminal repeats in the central nervous system of transgenic mice. Science 1992; 258: 1804–1808
   PubMed Web of Science ®Google Scholar
• Daenke S, Nightendale S, Cruickshank J K, Bangham C RM. Sequence variants of human T-cell lymphotropic virsus type I from patients with tropical spastic paraparesis and adult T-cell leukemia do not distinguish neurological from leukemic isolates. J Virol 1990; 64: 1278–1282
   PubMedGoogle Scholar
• Delmas V, Laoide B M, Masquilier D, de Groot R P, Foulkes N S, Sassone-Corsi P. Alternative usage of initiation codones in mRNA encoding the cAMP. responsive-element modulator generates regulators with opposite functions. Proc Natl Acad Sci USA 1992; 89: 4226–4230
   PubMedGoogle Scholar
• Dignam J D, Lebovitz R M, Roeder R G. Accurate transcription initiation by RNA polymerase II in a soluble extract from isolated mammalian nuclei. Nucleic Acids Res 1983; 11: 1475–1489
   PubMed Web of Science ®Google Scholar
• Felber B K, Paskalis H, Kleinman-Ewing C, Wong-Staal F, Pavlakis G N. The pX protein of HTLV-I is a transcriptional activator of its long terminal repeats. Science 1985; 229: 675–679
   PubMed Web of Science ®Google Scholar
• Foulkes N S, Borelli E, Sassone-Corsi P. CREM gene: Use of alternative DNA-binding domains generates multiple antagonists of CAMP-induced transcription. cell 1991; 64: 739–749
   PubMed Web of Science ®Google Scholar
• Fujisawa J-I, Toita M, Yoshimura T, Yoshida M. The indirect association of human T-cell leukemia virus tax protein with DNA results in transcriptional activation. J Virol 1991; 65: 4525–4528
   PubMedGoogle Scholar
• Garner M M, Revzin A. A gel electrophoresis method for quantifying the binding of DNA regions: application to components of the Escherichia coli lactose operon regulatory system. Nucleic Acids Res 1981; 9: 3047–3060
   PubMed Web of Science ®Google Scholar
• Gessain A, Vernant J C, Maurs L, Barin F, Cout O, Celander A., de The G. Antibodies to hman T-lymphotropic virus type I in patients with tropical spastic paraparesis. Lancet 1985; 24: 407–410
   Google Scholar
• Giam C-Z, Xu Y-L. HTLV-I tax gene product activates transcription via pre-existing cellular factors and CAMP responsive element. J Biol Chem 1989; 264: 15236–15241
   PubMed Web of Science ®Google Scholar
• Gonzalez-Dunia D, Grimber D G, Briand P, Brahic M, Ozden S. Tissue expression pattern directed in transgenic mice by the LTR of an HTLV-I provirus isolated from a case of tropical spastic paraparesis. Virology 1992; 187: 705–710
   Google Scholar
• Hai T-Y, Liu F, Couko W, Green M. Transcription factor ATF cDNA clones: an extensive family of leucine zipper proteins able to selectively form DNA binding heterodimers. Genes Dev 1989; 3: 2083–2090
   PubMed Web of Science ®Google Scholar
• Iannone R, Sherman M P, Rodgers-Johnson P EB, Beilke M A, Mora C A, Amin R M, Tinsley S R, Papsidero L D, Poiesz B J, Gibbs C J. HTLV-I DNA sequences in CNS tissue of a patient with tropical spastic paraparesis and HTLV-I myelopathy. J Acquir Immune Defic Syndr 1992; 5: 810–816
   Google Scholar
• Kira J-I, Itoyama Y, Koyanagi Y, Tateishi J, Kiskikawa M, Akizuki S-I, Kobayashi I, Toki N, Sueishi K, Sato H, Sakaki Y, Yamamoto N, Goto I. Presence of HTLV-I proviral DNA in central nervous system of patients with HTLV-I-associated myelopathy. Ann Neurol 1992; 31: 39–45
   PubMedGoogle Scholar
• Komurian F, Pelloquin F, de The G. In vivo, genomic variability of human T-cell leukemia virus type I depends more upon geography than upon pathologies. J Virol 1991; 65: 3770–3778
   Google Scholar
• Laoide B M, Foulkes N S, Schlotter F, Sassone-Corsi P. The functional versatility of CREM is determined by its modular structure. EMBO J 1993; 12: 1179–1191
   PubMedGoogle Scholar
• Lee K. Dimeric transcription factor families: it takes two to tango but who decides on partners and the venue?. J Cell Sci 1992; 103: 9–14
   PubMed Web of Science ®Google Scholar
• Li Y, Golemis E, Hartley J W, Hopkins N. Disease specificity of nondefective Friend and Moloney murine leukemia viruses is controlled by a small number of nucleotides. J Virol 1987; 61: 693–700
   PubMedGoogle Scholar
• Malik K, Even J, Karpas A. Molecular cloning and complete nucleotide sequence of an adult T-cell leukeamia virus/human T-cell leukaemia virus type I (ATLV/HTLV-I) isolate of Caribbean origin: relationship to other members of the ATLV/HTLV-I subgroup. J Gen Virol 1988; 69: 1695–1710
   PubMedGoogle Scholar
• Matthews M-AH, Markowitz R-B, Dynan W S. In vitro, activation of transcription by the human T-cell leukemia virus type I tax protein. Mol Cell Biol 1992; 12: 1986–1996
   PubMedGoogle Scholar
• Nakamura M, Niki M, Ohtani K, Sugamura K. Differential activation of the 21-base-pair enhancer element of human T-cell leukemia virus type I by its own trans-activator and cyclic AMP. Nucleic Acids Res 1989; 17: 5208–5221
   Google Scholar
• Niki M, Ohtani K, Nakamura M, Sugamura K. Multistep regulation of enhancer activity of the 21-base-pair element of human T-cell leukemia virus type. I. J Biol Chem 1992; 265: 2537–2542
   Google Scholar
• Nyborg J K, Dynan W S. Interaction of cellular proteins with the human T-cell leukemia virus type I transcriptional control region (Part I). J Biol Chem 1990; 265: 8230–8236
   PubMedGoogle Scholar
• Paca-Uccaralertuken S, Zhao L-J, Adya N, Cross J V, Cullen B R, Boros I M, Giam C-G. In vitro, selection of DNA elements highly responsive to the human T-cell lymphotropic virus type I transcriptional activator, Tax. Mol Cell Biol 1994; 14: 456–462
   Google Scholar
• Paquette Y, Hanna Z, Savard P, Brousseau R, Robitaille Y, Jolicoeur P. Retrovirus-induced murine motor neuron disease: Mapping the determinant of spongiform degeneration within the envelope gene. Proc Natl Acad Sci USA 1989; 86: 3896–3900
   PubMed Web of Science ®Google Scholar
• Park R E, Haseltine W A., Rosen C A. A nuclear factor is required for transactivation of HTLV-I gene expression. Oncogene 1988; 3: 275–279
   PubMedGoogle Scholar
• Paskalis H, Felber B K, Pavlakis G N. Cis-acting sequences responsible for the transcriptional activation of human T-cell leukemia virus type I constitute a conditional enhancer. Proc Natl Acad Sci USA 1986; 83: 6558–6562
   PubMedGoogle Scholar
• Popovic M, Sarin P S, Robert-Gurroff M, Kalyanaraman V S, Mann D, Minowada J, Gallo R C. Isolation and transmission of human retrovirus (Human T-cell leukemia virus). Science 1983; 219: 856–859
   PubMed Web of Science ®Google Scholar
• Rosen C A, Haseltine W A, Lenz J, Ruprecht R, Cloyd M W. Tissue selectivity of murine leukemia virus infection is determined by long terminal repeat sequences. J Virol 1985; 55: 862–866
   PubMedGoogle Scholar
• Rosen C A, Park R, Sodroski J G, Haseltine W A. Multiple sequence elements are required for regulation of human T-cell leukemia virus gene expression. Proc Natl Acad Sci USA 1987; 84: 4919–4923
   PubMedGoogle Scholar
• Rosen C A, Sodroski J G, Haseltine W A. Location of cis-acting regulatory sequences in the human T-cell leukemia virus type I long terminal repeat. Proc Natl Acad Sci USA 1985; 82: 6502–6506
   PubMed Web of Science ®Google Scholar
• Seiki M, Inoue J-I, Takeda T, Yoshida M. Direct evidence that p40x of human T-cell leukemia virus type I is a trans-acting transcriptional activator. EMBO J 1986; 5: 561–565
   PubMed Web of Science ®Google Scholar
• Sherman M P, Saksena N K, Dube D K, Yanagihara R, Poiesz B J. Evolutionary insights on the origin of human T-cell lymphoma/leukemia virus type I (HTLV-I) derived from sequence analysis of a new HTLV-I variant from Papua New Guinea. J Virol 1992; 66: 2556–2563
   PubMed Web of Science ®Google Scholar
• Shimotohno K, Takano M, Teruuchi T, Miwa M. Requirement of multiple copies of a 21-nucleotide sequence in the U3 regions of human T-cell leukemia virus type I and type II long terminal repeats for transacting activation of transcription. Proc Natl Acad Sci USA 1986; 83: 8112–8116
   PubMed Web of Science ®Google Scholar
• Sodroski J G, Rosen C A, Haseltine W A. Trans-acting transcriptional activation of the long terminal repeat of human T lymphotropic viruses in infected cells. Science 1984; 225: 381–385
   PubMed Web of Science ®Google Scholar
• Sodroski J G. The human T-cell leukemia virus (HTLV) transactivator (Tax) protein. Biochem Biophys Acta 1992; 1114: 19–29
   PubMedGoogle Scholar
• Suzuki T, Fujisawa J-I, Toita M, Yoshida M. The trans-activator Tax of human T-cell leukemia virus type 1 (HTLV-1) interacts with CAMP-responsive element (CRE) binding and CRE modulator proteins that bind to the 21-base-pair enhancer of HTLV-1. Proc Natl Acad Sci USA 1993; 90: 610–614
   PubMed Web of Science ®Google Scholar
• Tillmann M, Wessner R, Wigdahl B. Identification of human T-cell lymphotropic virus type I 21-base-pair repeat-specific and glial cell-specific DNA-protein complexes. J Virol 1994; 68: 4597–4608
   Google Scholar
• Tillmann M, Krebs F C, Wessner R, Pomeroy S M, Goodenow M M, Wigdahl B. Neuroglial-specific factors and the regulation of retrovirus transcription. Adv Neuroimmunol 1994; 4: 305–318
   Google Scholar
• Tillmann M, Wigdahl B. Identification of HTLV-I 21 bp repeat-specific DNA-protein complexes. Leukemia 1994; 8: S83–S87
   Google Scholar
• Watanabe T, Seiki M, Yoshida M. HTLV type I (US isolate) and ATLV (Japanese isolate) are the same species of human retrovirus. Virology 1984; 133: 238–241
   PubMed Web of Science ®Google Scholar
• Wong-Staal F, Gallo R C. The family of human Tlymphotropic leukemia viruses: HTLV-I as a cause of adult T cell leukemia and HTLV-III as the cause of acquired immunodeficiency syndrome. Blood 1985; 65: 253–263
   PubMed Web of Science ®Google Scholar
• Zhao L J, Giam C Z. Human T-cell lymphotropic virus type I (HTLV-I) transcriptional activator, Tax enhances CREB binding to the HTLV-I 21-base-pair repeats by protein-protein interaction. Proc Natl Acad Sci USA 1991; 89: 7070–7074
   Google Scholar